ADAP/manufacturer agreements
Executive Summary
Pfizer, GlaxoSmithKline and Boehringer-Ingelheim agree to provide additional aid to AIDS Drug Assistance Programs. GSK will offer a "$20 mil. financial aid package" to ADAPs to help cut waiting lists and avoid program restrictions, company says. Pfizer is offering its antiretroviral drugs Viracept and Rescriptor "either free or at greatly discounted prices" and will "maintain price neutrality" on its new 625 mg Viracept formulation compared to older formulations, Pfizer says. Negotiations with Bristol-Myers Squibb continue (1"The Pink Sheet" May 19, 2003, In Brief)...